Physician profile
Thomas Jude Christopher
NPI 1790782886
$6,233.37
in general payments reported to CMS, 2019-2025
16 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $40.59 · 2021: $1,225 · 2022: $573 · 2023: $497 · 2024: $1,438 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,955.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,438.02 | 2019-2025 | Acticor 7 Vr-T Dx, Selectra, Edora 8 Dr-T |
| Medtronic, INC. | $1,202.58 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Pulseselect |
| Abbott Laboratories | $718.58 | 2019-2025 | Ensite, Aveir, Jot Dx |
| Elutia, INC. | $575.87 | 2019-2024 | Ecm Patch,Pouch |
| Altathera Pharmaceuticals LLC | $500.00 | 2021 | |
| Boston Scientific Corporation | $440.35 | 2019-2025 | Watchman Flx |
| Atricure, INC. | $385.70 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Impulse Dynamics (USA) INC. | $354.96 | 2022-2023 | Optimizer |
| Edwards Lifesciences Corporation | $170.29 | 2025 | Evoque |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $128.45 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $90.45 | 2023-2024 | Assure Wcd |
| Medtronic Vascular, INC. | $74.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $53.17 | 2019-2020 | |
| Biosense Webster, INC. | $50.42 | 2024-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $39.09 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.